Developing a standardized kit and normal reference profile for circular RNAs in the nervous system

Information

  • Research Project
  • 8841991
  • ApplicationId
    8841991
  • Core Project Number
    R43DA038993
  • Full Project Number
    1R43DA038993-01
  • Serial Number
    038993
  • FOA Number
    RFA-DA-15-001
  • Sub Project Id
  • Project Start Date
    9/1/2014 - 11 years ago
  • Project End Date
    2/28/2015 - 10 years ago
  • Program Officer Name
    BOUGH, KRISTOPHER J.
  • Budget Start Date
    9/1/2014 - 11 years ago
  • Budget End Date
    2/28/2015 - 10 years ago
  • Fiscal Year
    2014
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/22/2014 - 11 years ago
Organizations

Developing a standardized kit and normal reference profile for circular RNAs in the nervous system

DESCRIPTION (provided by applicant): Modified ribonucleic acids (RNA) are important regulators of translation and other cellular pathways. Non- coding RNAs like microRNAs play significant roles in neuronal development, and can serve as biomarkers for psychiatric disorders. Another such modified RNA is circular RNA (circRNA), a non-coding transcript present in the cytoplasm. Since circRNAs are present in lower abundance than other RNA molecules, and share sequence homology with mRNA, they are difficult to isolate from total RNA. To facilitate identification and examination of these molecules, we propose to develop a streamlined approach that uses selective reduction of linear and ribosomal RNAs combined with a novel reverse transcriptase to enrich for circular RNAs. To optimize for robust reduction and amplification, we will test a range of conditions and assess their relative efficiencies using qRT-PCR specific for known circRNAs and synthetic spiked-in linear RNAs. We will use our validated approach to generate circRNA profiles of multiple brain tissues, which will be of significant benefit to researchers interested in understanding the role of circRNA in neuronal development, substance abuse, and psychiatric disorders. As there is no kit on the market which addresses the need for easy circRNA enrichment, development of this protocol will foster broader research in this nascent field and further understanding of the role of circRNAs.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R43
  • Administering IC
    DA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    161499
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
  • Funding ICs
    NIDA:161499\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZDA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    COFACTOR GENOMICS, LLC
  • Organization Department
  • Organization DUNS
    015692177
  • Organization City
    SAINT LOUIS
  • Organization State
    MO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    631101716
  • Organization District
    UNITED STATES